Liraglutide promotes diabetic corneal epithelial and nerve regeneration by suppressing oxidative stress via the PI3K/AKT signalling pathway
European Journal of Pharmacology · 2025
DOI: 10.1016/j.ejphar.2025.178264 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Wentao Han und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China; Hunan Clinical Research Center …. Hauptthemen laut MEDLINE: Liraglutide, Oxidative Stress, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Health Commission of Hunan Province, Natural Science Foundation of Hunan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
AIMS: Although clinical evidence suggested that glucagon-like peptide-1 (GLP-1) receptor agonists exhibit neuroprotective properties in patients with diabetic peripheral neuropathy, their therapeutic potential in diabetic keratopathy (DK) remains unexplored. This study investigates the neuroprotective and wound-healing effects of liraglutide in DK through PI3K/AKT pathway activation and oxidative stress amelioration. METHODS: In vitro, we evaluated the effects of liraglutide on migration, oxidative stress, and apoptosis in human corneal epithelial cells (HCECs). Axonal outgrowth was quantified in the primary trigeminal ganglion neurons cultured under high glucose conditions. The role of the PI3K/AKT pathway was confirmed using specific pharmacological inhibitors. In vivo, diabetic mice were treated with liraglutide, and clinical outcomes (corneal fluorescein scores, tear production, sensitivity, goblet cell density) were measured. Corneal tissues were analysed for PI3K/AKT activation, wound healing, and nerve regeneration. Additional experiments using PI3K inhibitors were performed to confirm the pathway's involvement. RESULTS: Our in vitro experiments demonstrated that liraglutide promoted HCECs migration, reduced oxidative stress, and inhibited apoptosis via activation of the PI3K/AKT pathway. Additionally, liraglutide enhanced axonal outgrowth in high glucose-treated primary trigeminal ganglion neurons through the same mechanism. In vivo, liraglutide treatment significantly improved clinical outcomes in diabetic mice, including reduced corneal fluorescein staining, increased tear production, improved corneal sensitivity, and restoration of conjunctival goblet cell density. Mechanistically, liraglutide activated PI3K/AKT signalling in the diabetic cornea, promoting wound healing and nerve regeneration by mitigating oxidative stress. These beneficial effects were abolished upon PI3K pathway inhibition. CONCLUSIONS: These findings provide strong preclinical evidence supporting the therapeutic potential of liraglutide for the treatment of DK.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, Hunan, 410011, China.
- Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, Hunan, 410011, China. Electronic addr…
Förderung
- Health Commission of Hunan Province
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Han, W., Dai, S., Sun, X., Liu, S., Zhang, L., & Chen, B. (2025). Liraglutide promotes diabetic corneal epithelial and nerve regeneration by suppressing oxidative stress via the PI3K/AKT signalling pathway. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178264
Vancouver
Han W, Dai S, Sun X, Liu S, Zhang L, Chen B. Liraglutide promotes diabetic corneal epithelial and nerve regeneration by suppressing oxidative stress via the PI3K/AKT signalling pathway. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.178264
BibTeX
@article{Han2025,
author = {Han, Wentao and Dai, Shirui and Sun, Xinyue and Liu, Shaohua and Zhang, Liwei and Chen, Baihua},
title = {Liraglutide promotes diabetic corneal epithelial and nerve regeneration by suppressing oxidative stress via the PI3K/AKT signalling pathway},
journal = {European Journal of Pharmacology},
year = {2025},
doi = {10.1016/j.ejphar.2025.178264}
}
EUVIMED